Mixed-methods economic evaluation of the implementation of tobacco treatment programs in National Cancer Institute-designated cancer centers

被引:16
|
作者
Salloum, Ramzi G. [1 ]
D'Angelo, Heather [2 ]
Theis, Ryan P. [1 ]
Rolland, Betsy [2 ,3 ]
Hohl, Sarah [2 ]
Pauk, Danielle [2 ]
LeLaurin, Jennifer H. [1 ]
Asvat, Yasmin [4 ,5 ]
Chen, Li-Shiun [6 ]
Day, Andrew T. [7 ]
Goldstein, Adam O. [8 ]
Hitsman, Brian [9 ,10 ]
Hudson, Deborah [11 ]
King, Andrea C. [12 ]
Lam, Cho Y. [13 ]
Lenhoff, Katie [14 ]
Levinson, Arnold H. [15 ]
Prochaska, Judith [16 ]
Smieliauskas, Fabrice [17 ]
Taylor, Kathryn [18 ]
Thomas, Janet [19 ]
Tindle, Hilary [20 ]
Tong, Elisa [21 ]
White, Justin S. [22 ]
Vogel, W. Bruce [1 ]
Warren, Graham W. [23 ]
Fiore, Michael [2 ,3 ,24 ]
机构
[1] Univ Florida, Coll Med, Dept Hlth Outcomes & Biomed Informat, 2004 Mowry Rd, Gainesville, FL 32603 USA
[2] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[3] Univ Wisconsin, Inst Clin & Translat Res, Madison, WI USA
[4] Rush Univ, Med Ctr, Chicago, IL USA
[5] Rush Canc Ctr, Chicago, IL USA
[6] Washington Univ, Siteman Canc Ctr, St Louis, MO USA
[7] Univ Texas Southwestern Med Ctr, Dallas, TX USA
[8] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC USA
[9] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[10] Northwestern Univ, Lurie Comprehens Canc Ctr, Chicago, IL USA
[11] Indiana Univ, Simon Canc Ctr, Indianapolis, IN USA
[12] Univ Chicago Med, Comprehens Canc Ctr, Chicago, IL USA
[13] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[14] Dartmouth Hitchcock Norris Cotton Canc Ctr, Lebanon, NH USA
[15] Univ Colorado, Comprehens Canc Ctr, Aurora, CO USA
[16] Stanford Univ, Stanford Canc Inst, Stanford, CA USA
[17] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[18] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[19] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[20] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[21] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA USA
[22] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94118 USA
[23] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC USA
[24] Univ Wisconsin, Ctr Tobacco Res & Intervent, Madison, WI USA
来源
关键词
Implementation costs; Economic evaluation; Mixed methods; Smoking cessation; Tobacco treatment; SMOKING-CESSATION; CLINICAL-PRACTICE; COST-EFFECTIVENESS; NECK-CANCER; RECOMMENDATIONS; MORTALITY; SURVIVORS; HEAD;
D O I
10.1186/s43058-021-00144-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background The Cancer Center Cessation Initiative (C3I) was launched in 2017 as a part of the NCI Cancer Moonshot program to assist NCI-designated cancer centers in developing tobacco treatment programs for oncology patients. Participating centers have implemented varied evidence-based programs that fit their institutional resources and needs, offering a wide range of services including in-person and telephone-based counseling, point of care, interactive voice response systems, referral to the quitline, text- and web-based services, and medications.Methods We used a mixed methods comparative case study design to evaluate system-level implementation costs across 15 C3I-funded cancer centers that reported for at least one 6-month period between July 2018 and June 2020. We analyzed operating costs by resource category (e.g., personnel, medications) concurrently with transcripts from semi-structured key-informant interviews conducted during site visits. Personnel salary costs were estimated using Bureau of Labor Statistics wage data adjusted for area and occupation, and non-wage benefits. Qualitative findings provided additional information on intangible resources and contextual factors related to implementation costs.Results Median total monthly operating costs across funded centers were $11,045 (range: $5129-$20,751). The largest median operating cost category was personnel ($10,307; range: $4122-$19,794), with the highest personnel costs attributable to the provision of in-person program services. Monthly (non-zero) cost ranges for other categories were medications ($17-$573), materials ($6-$435), training ($96-$516), technology ($171-$2759), and equipment ($10-$620). Median cost-per-participant was $466 (range: $70-$2093) and cost-per-quit was $2688 (range: $330-$9628), with sites offering different combinations of program components, ranging from individually-delivered in-person counseling only to one program that offered all components. Site interviews provided context for understanding variations in program components and their cost implications.Conclusions Among most centers that have progressed in tobacco treatment program implementation, cost-per-quit was modest relative to other prevention interventions. Although select centers have achieved similar average costs by offering program components of various levels of intensity, they have varied widely in program reach and effectiveness. Evaluating implementation costs of such programs alongside reach and effectiveness is necessary to provide decision makers in oncology settings with the important additional information needed to optimize resource allocation when establishing tobacco treatment programs.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Mixed-methods economic evaluation of the implementation of tobacco treatment programs within NCI-designated cancer centers
    Salloum, Ramzi
    D'Angelo, Heather
    Theis, Ryan
    LeLaurin, Jennifer
    Pauk, Danielle
    Chen, Li-Shiun
    Day, Andrew
    Goldstein, Adam
    Hitsman, Brian
    Hudson, Deborah
    King, Andrea
    Lam, Cho
    Levinson, Arnold
    Prochaska, Judith
    Tanski, Susanne
    Taylor, Kathryn
    Thomas, Janet
    Tindle, Hilary
    Tong, Elisa
    Warren, Graham
    Baker, Timothy
    Fiore, Michael
    [J]. IMPLEMENTATION SCIENCE, 2021, 16 (SUPPL 1):
  • [2] Tobacco Treatment Programs at National Cancer Institute-designated Cancer Centers A Systematic Review and Online Audit
    Day, Andrew T.
    Tang, Liyang
    Karam-Hage, Maher
    Fakhry, Carole
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (04): : 407 - 410
  • [3] The Impact of the COVID-19 Pandemic on Tobacco Treatment Program Implementation at National Cancer Institute-Designated Cancer Centers
    Hohl, Sarah D.
    Shoenbill, Kimberly A.
    Taylor, Kathryn L.
    Minion, Mara
    Bates-Pappas, Gleneara E.
    Hayes, Rashelle B.
    Nolan, Margaret B.
    Simmons, Vani N.
    Steinberg, Michael B.
    Park, Elyse R.
    Ashing, Kimlin
    Beneventi, Diane
    Cox, Lisa Sanderson
    Goldstein, Adam O.
    King, Andrea
    Kotsen, Chris
    Presant, Cary A.
    Sherman, Scott E.
    Sheffer, Christine E.
    Warren, Graham W.
    Adsit, Robert T.
    Bird, Jennifer E.
    D'Angelo, Heather
    Fiore, Michael C.
    Nguyen, Claire Van Thanh
    Pauk, Danielle
    Rolland, Betsy
    Rigotti, Nancy A.
    [J]. NICOTINE & TOBACCO RESEARCH, 2023, 25 (02) : 345 - 349
  • [4] Assessment of Parking Fees at National Cancer Institute-Designated Cancer Treatment Centers
    Lee, Anna
    Shah, Kanan
    Chino, Fumiko
    [J]. JAMA ONCOLOGY, 2020, 6 (08) : 1295 - 1297
  • [5] Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute-Designated Cancer Center
    Furlan, Julio C.
    Furlan, Daniel T.
    Marquez-Chin, Cesar
    [J]. JCO ONCOLOGY PRACTICE, 2022, 18 (02) : 184 - 190
  • [6] The Prevalence of Dissemination and Implementation Research and Training Grants at National Cancer Institute-Designated Cancer Centers
    Mueller, Nora M.
    Hsieh, Ada
    Ramanadhan, Shoba
    Lee, Rebekka M.
    Emmons, Karen M.
    [J]. JNCI CANCER SPECTRUM, 2022, 6 (01)
  • [7] Utilization of National Cancer Institute-Designated Cancer Centers by Medicare Beneficiaries with Cancer
    Erfani, Parsa
    Ojo, Ayotomiwa
    Orav, E. John
    Chino, Fumiko
    Lam, Miranda B.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (12) : 7250 - 7258
  • [8] Utilization of National Cancer Institute-Designated Cancer Centers by Medicare Beneficiaries with Cancer
    Parsa Erfani
    Ayotomiwa Ojo
    E. John Orav
    Fumiko Chino
    Miranda B. Lam
    [J]. Annals of Surgical Oncology, 2022, 29 : 7250 - 7258
  • [9] Integrating Tobacco Treatment Into Oncology Care: Reach and Effectiveness of Evidence-Based Tobacco Treatment Across National Cancer Institute-Designated Cancer Centers
    Hohl, Sarah D.
    Matulewicz, Richard S.
    Salloum, Ramzi G.
    Ostroff, Jamie S.
    Baker, Timothy B.
    Schnoll, Robert
    Warren, Graham
    Bernstein, Steven L.
    Minion, Mara
    Lenhoff, Katie
    Dahl, Neely
    Juon, Hee Soon
    Tsosie, Ursula
    Fleisher, Linda
    D'Angelo, Heather
    Ramsey, Alex T.
    Ashing, Kimlin T.
    Rolland, Betsy
    Nolan, Margaret B.
    Bird, Jennifer E.
    Nguyen, Claire V. T.
    Pauk, Danielle
    Adsit, Robert T.
    Tindle, Hilary A.
    Shoenbill, Kimberly
    Yeung, Sophia
    Presant, Cary A.
    Wiseman, Kara P.
    Wen, Kuang-Yi
    Chichester, Lou-Anne
    Chen, Li-Shiun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2756 - +
  • [10] Understanding Thyroidectomy Cost Variations Among National Cancer Institute-Designated Cancer Centers
    Si-Yuan Wu
    John Terrell
    Anne Park
    Nancy Perrier
    [J]. World Journal of Surgery, 2020, 44 : 385 - 392